Clinical trial
A Pilot Study to Evaluate the Feasibility and Safety of Performing a Double Blind, Placebo-controlled, Randomized Controlled Trial of the Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment
NCT02407821 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study to Evaluate the Feasibility and Safety of Performing a Double Blind, Placebo-controlled, Randomized Controlled Trial of the Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment
- Lead sponsor
- University Health Network, Toronto
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2015
- Completion date
- January 31, 2017
- Enrollment
- 25 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease